Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2013
10/16/2013CN102276727B IL-17RC-hFc fusion protein and application thereof
10/16/2013CN102209550B Composition for cancer prevention or treatment containing as active ingredient plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng
10/16/2013CN102051362B Interference RNA (Ribonucleic Acid) of targeted HPIP (hematopoietic PBX-interacting protein) gene, medical composition containing same and application thereof
10/16/2013CN101936984B Method and special chemical luminous immunoassay kit for detecting clenbuterol
10/16/2013CN101935342B Moth orchid development B gene-PhAP3 coded sequence and application thereof
10/16/2013CN101806804B Reagent for detecting acute myocardial infarction by immunological method and test strip
10/16/2013CN101535344B Novel antiproliferation antibodies
10/16/2013CN101245101B Antihuman CD146 monoclone antibody, composition containing the same, and method for testing dissolubility CD146
10/15/2013US8558094 Inbred sunflower (Helianthus annuus) line, designated OID687R
10/15/2013US8558093 Inbred sunflower (Helianthus annuus) line, designated CN5190R
10/15/2013US8558087 Hybrid corn variety 980004
10/15/2013US8558084 Plants and seeds of corn variety CV198691
10/15/2013US8558072 Soybean variety XBP32005
10/15/2013US8558069 Inbred Cucurbita pepo pumpkin HSPMR7B1 having a mutant allele for powdery mildew resistance
10/15/2013US8558068 Sclerotinia-resistant Brassica
10/15/2013US8558067 Sclerotinia-resistant brassica
10/15/2013US8558066 Sclerotinia-resistant Brassica
10/15/2013US8557967 Anti-interferon-α antibodies
10/15/2013US8557785 In vivo production of small interfering RNAS that mediate gene silencing
10/15/2013US8557584 Preparing a homogenous population of stem cells committed to differentiated to a specific cell type
10/15/2013US8557583 Cell culture support and manufacture thereof
10/15/2013US8557582 System, apparatus and method for applying mechanical force to a material
10/15/2013US8557581 Soft tissue processing
10/15/2013US8557580 Methods and compositions for the differentiation of stem cells
10/15/2013US8557579 Screening for modulators of PSGL-1 with respect to T cell or NK cell death
10/15/2013US8557577 Solid phase cell isolation and/or enrichment method
10/15/2013US8557576 Mineralized three-dimensional bone constructs
10/15/2013US8557575 Fusion partner cell line for preparation of hybrid cells expressing human antibodies
10/15/2013US8557574 Fungal growth inhibitor
10/15/2013US8557547 Phosphotriesterase from agrobacterium radiobacter P230
10/15/2013US8557543 Polypeptides specifically binding to vascular endothelial growth factor receptor-2 and methods therefor
10/15/2013US8557533 Screening method for the identification of agents capable of activating CD4+CD25+ regulatory T-cells through interactions with the HIV-1 GP120 binding site on CD4
10/15/2013US8557513 Methods for treating and/or limiting development of diabetes
10/15/2013US8557512 Method of screening activators and/or inhibitors of insulin receptor substrate 2
10/15/2013US8557295 Use of cellular extracts for skin rejuvenation
10/15/2013US8557246 Fusion protein that directs vaccine antigens to antigen-presenting cells, and applications thereof
10/15/2013US8557235 Bone substitute compositions, methods of preparation and clinical applications
10/15/2013CA2715103C Monoclonal antibody which binds met in formalin-fixed and paraffin-embedded tissues and related methods
10/15/2013CA2673085C Transferrin fusion protein libraries
10/15/2013CA2555699C Monoclonal antibody based biomarker discovery and development platform
10/15/2013CA2533926C Methods and compositions for producing antigenic responses
10/15/2013CA2521946C Method of identifying transmembrane protein-interacting compounds
10/15/2013CA2494844C Methods and compositions concerning poxviruses and cancer
10/15/2013CA2452119C Polynucleotides encoding antigenic hiv type b and/or type c polypeptides, polypeptides and uses thereof
10/15/2013CA2410762C Feline hepatocyte growth factor
10/15/2013CA2402214C T1r taste receptors and genes encoding same
10/15/2013CA2373721C Compounds that bind her2
10/15/2013CA2333146C Commercial production of proteases in plants
10/15/2013CA2296434C Mutations in the myostatin gene cause double-muscling in mammals
10/15/2013CA2236749C Neuronal stimulation using electrically conducting polymers
10/10/2013WO2013152274A1 Epitope- scaffold immunogens against respiratory syncytial virusm (rsv)
10/10/2013WO2013151735A1 Method to mitigate long-qt arrhythmias
10/10/2013WO2013151725A1 Regenerative sera cells and mesenchymal stem cells
10/10/2013WO2013151186A1 Method for inducing erythropoietin-producing cell
10/10/2013WO2013151058A1 DNA CONTROLLING miR-140 EXPRESSION, AND SCREENING METHOD OF DRUGS USING SAID DNA
10/10/2013WO2013150400A1 Plants having one or more enhanced yield-related traits and method for making same
10/10/2013WO2013150303A1 Stem cell microparticles
10/10/2013WO2013150138A1 Secretory immunoglobulin complex
10/10/2013WO2013149957A1 Improved culture media for embryonic cells
10/10/2013US20130269065 Blackleg resistance gene
10/10/2013US20130269047 Tomato hybrid px 02461513 and parents thereof
10/10/2013US20130268060 Method for differentiating embryonic stem cells into cells expressing aqp-1
10/10/2013US20130267684 Method for preparing aqueous solution containing culture medium and chelating agent
10/10/2013US20130267676 Artificial antibody polypeptides
10/10/2013US20130267468 Factor viii glycoforms
10/10/2013US20130267455 Crosslinked peptide hydrogels
10/10/2013US20130267030 Efficient method for establishing induced pluripotent stem cells
10/10/2013US20130267027 Dry granulated cell culture media
10/10/2013US20130267026 Methods of building a body portion
10/10/2013US20130267024 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer
10/10/2013US20130267023 Multiple Inducible Gene Regulation System
10/10/2013US20130267008 Freezing medium composition for cryopreserving amniotic fluid-derived stem cells and a method for cryopreserving the same
10/10/2013US20130266985 Process for Cell Culturing by Continuous Perfusion
10/10/2013US20130266954 Method for forming a cell aggregate
10/10/2013US20130266939 Systems and methods for studying inflammation-drug interactions
10/10/2013US20130266628 Graphene-based antimicrobial composites
10/10/2013US20130266573 Specific binding proteins and uses thereof
10/10/2013US20130266553 Albumin Fusion Proteins
10/10/2013US20130266544 Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
10/10/2013US20130266543 Multipotent Adult Stem Cell Population
10/10/2013US20130266541 Human induced pluripotent stem cells
10/10/2013DE102010022675B4 Verfahren zur Herstellung einer Hydrogel-Mikrostruktur A process for the preparation of a hydrogel microstructure
10/10/2013CA2808845A1 Promoters and methods for transforming tubers and transformed tubers
10/09/2013EP2647707A1 Cytotoxicity-inducing therapeutic agent
10/09/2013EP2647700A1 Method for increasing efficiency of generating inducted pluripotent stem cell
10/09/2013EP2647699A1 Efficient method for establishing induced pluripotent stem cells
10/09/2013EP2647698A1 Method for production of eosinophil from pluripotent stem cell
10/09/2013EP2647697A1 Method for producing hematopoietic stem cells using pyrazole compound
10/09/2013EP2647384A1 IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM Va-Ja , AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS
10/09/2013EP2646557A1 Method for cellular rna expression
10/09/2013EP2646546A1 Tomm34 peptides and vaccines including the same
10/09/2013EP2646545A1 TEMPERATURE-STABLE ß-PYRANOSIDASE
10/09/2013EP2646543A1 Methods of generating corneal cells and cell populations comprising same
10/09/2013EP2646045A1 Chemical and rnai suppressors of neurotoxicity in huntington's disease
10/09/2013EP2646007A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
10/09/2013CN103348012A Humanized transgenic animal
10/09/2013CN103348003A Fusion enzymes having N-acetylglucosaminyl transferase activity
10/09/2013CN103348002A Method of generating induced pluripotent stem cells and differentiated cells
10/09/2013CN103348001A Highly functional liver cells derived from pluripotent stem cells, method for producing same, and method for testing metabolism/toxicity of drug
10/09/2013CN103348000A Compositions and methods for stabilizing susceptible compounds